TURENNE ANDRE (President & CEO) sold 5.1% of their position (7.98K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $60.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/16/2021ACC: 0001104659-21-023993
DirectorOfficer· President & CEO
Since Jul 2018
-7.98K
Net shares
Net seller
$60.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.98K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.98K
Price / share
$7.55
Trade value
$60.23K
% of position
5.1%
2/11/2021
156.35K→148.38K
Total
Net shares
−7.98K
Net value
-$60.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2021 | S · Sale | −7.98K | $7.55 | $60.23K | 5.1% | 156.35K | 148.38K |
| Total | −7.98K | -$60.23K | ||||||
Derivative Transactions0
No derivative transactions reported